Zurich Cantonal Bank Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Transocean
RIG
|
+$28.2M |
| 2 |
T-Mobile US
TMUS
|
+$14.1M |
| 3 |
MON
Monsanto Co
MON
|
+$11.3M |
| 4 |
Chevron
CVX
|
+$5.22M |
| 5 |
Unum
UNM
|
+$4.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$29.9M |
| 2 |
Gilead Sciences
GILD
|
+$22.7M |
| 3 |
Biogen
BIIB
|
+$17.2M |
| 4 |
CELG
Celgene Corp
CELG
|
+$17.2M |
| 5 |
Perrigo
PRGO
|
+$14.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.55% |
| 2 | Technology | 14.03% |
| 3 | Healthcare | 11.8% |
| 4 | Energy | 11.08% |
| 5 | Industrials | 8.36% |
Similar funds
Zurich Cantonal Bank's Q3 2014 Portfolio in Review
As of Q3 2014, Zurich Cantonal Bank held 1,024 positions worth $3.05B, down 10% from $3.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Zurich Cantonal Bank withdrew a net $388M in Q3 2014, closing 62 positions and reducing 323 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Zurich Cantonal Bank opened a new position in Weatherford International plc worth $1.78M.
- Zurich Cantonal Bank's largest Q3 2014 buy was Weatherford International plc: 85,470 shares worth $1.78M.
- Zurich Cantonal Bank added most to Transocean in Q3 2014, an estimated $28.2M increase.
- Zurich Cantonal Bank's biggest Q3 2014 reduction was Deutsche Bank, cutting an estimated $29.9M.
- Zurich Cantonal Bank fully exited Jazz Pharmaceuticals in Q3 2014, selling an estimated $10.3M.
- Zurich Cantonal Bank's ten largest holdings make up 19% of its $3.05B portfolio in Q3 2014.
- Zurich Cantonal Bank opened 24 new positions and closed 62 in Q3 2014.
- Zurich Cantonal Bank's portfolio value fell 10% quarter-over-quarter to $3.05B.
Based on Zurich Cantonal Bank's 13F filing for Q3 2014, filed 28 Oct 2014.